HIV INHIBITION COMPOUND - Gilead Sciences, Inc.

Title:

HIV INHIBITION COMPOUND

Document Type and Number:

Japanese Patent JP2022172294

Kind Code:

A

Abstract:

To provide a HIV inhibition agent compound.SOLUTION: A compound such as (Ia) below, or a pharmaceutically acceptable salt thereof, is provided.SELECTED DRAWING: None

More Like This:

WO/2021/066088	NOVEL TRIAZINE DERIVATIVE
WO/2001/087347	HETEROBIFUNCTIONAL CROSS-LINKING AGENT CONJUGATE SUBSTITUTED BY AN IMMUNOMODULATOR AND CELL RECOGNITION UNIT
JP2022513310	Matryptase 2 inhibitor and its use

Inventors:

Elizabeth M. Bacon
Elbert Chin
Jerome Jay Kottel
Ashley Ann Katana
Darryl Kato
John Oh Link
Nathan Shapiro
Teresa Alejandr Trejo Martin
Zen-Yu Yang

Application Number:

JP2022140748A

Publication Date:

November 15, 2022

Filing Date:

September 05, 2022

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Gilead Sciences, Inc.

International Classes:

C07D487/08; A61K31/4155; A61K31/4427; A61K31/4439; A61K31/496; A61K31/4985; A61K31/4995; A61K31/506; A61K31/519; A61K31/5365; A61K31/5383; A61K31/5386; A61K31/553; A61K31/675; A61K45/00; A61P31/18; A61P43/00; C07D231/12; C07D401/10; C07D401/12; C07D407/14; C07D413/14; C07D471/08; C07D487/04; C07D487/10; C07D491/107; C07D498/04; C07D498/08; C07D519/00

Attorney, Agent or Firm:

Shusaku Yamamoto
Morishita Natsuki

Previous Patent: Device-to-device (D2D) preemption and access control

Next Patent: Video encoding method, video decoding method, and recording medium